Aims-To survey the diagnostic service provided by UK laboratories for the culture of solid tissue samples (excluding tumours) and in particular to examine the variation in culture success rates and the problems of maternal cell overgrowth. Methods-Twenty seven laboratories took part in a collaborative survey during 1992. Each laboratory submitted data on up to a maximum of 60 consecutive specimens (n = 1361) over a six month period. Results-Skin specimens, the largest category received (n = 520), were the most problematic (51% success rate). Culture success rates were significantly lower (43%) when skin specinens (n = 140) were transported dry to the laboratory. Success rates for skin specimens also varied, depending on the origin of the specimen, from 18% for intra-uterine deaths (IUD) (n = 94) to 85% for neonatal deaths (n = 33) and 83% for live patients (n = 54). Culture of selected extra-fetal tissues from IUD, stillbirths and following elective termination of pregnancy (TOP) gave comparable success rates to those achieved for skin samples from neonatal deaths and live births. Skewed sex ratios, female > male, were identified for products of conception (POC) (n = 298) and placental biopsy specimens (n = 97). Conclusions-By appropriate selection, transport and processing of tissues, and in particular by avoiding relying solely on skin samples from IUD, stillbirths and TOP, an increase in culture success rates for solid tissue samples submitted for cytogenetic analysis could be achieved. The high risk of maternal cell contamination from POC and placental biopsy specimens was also identified in this survey. (J Clin Pathol 1996;49:638-641) 
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Discussion
The survey had a number of limitations. A proportion of the data was incomplete, with not all data for each specimen submitted. The available data from such specimens were included in the survey. Categories of specimen origin and the categories of specimen received were defined by the proforma. Category overlaps in terms of specimen origin-for example, IUD/spontaneous abortion and IUD/ TOP, were present. Part of the remit of the survey was to identify the reason for the low success rate for tissues cultured from IUD specimens. For this reason, data from such specimens were specifically requested and entered in the survey under the category of IUD. The data have been broken down into two groups, IUD < 28 weeks and IUD > 28 weeks to be comparable with the spontaneous abortion and stillbirth categories, respectively. The survey was initiated when the definition of a spontaneous abortion was defined as a miscarriage at less than 28 weeks. Some difficulty in interpretation of the data occurred with the categories of specimen received. In retrospect it could be seen that the category of fetus plus or minus ( ± ) placenta was too loosely defined. As a result it was not possible to determine whether extra-fetal tissues had not been cultured for reasons of policy or because extra-fetal tissue was not available. Despite its limitations, the survey did identify the poor culture success rates of the largest category of specimens received, skin samples, and ways in which success rates could be improved. This category included biopsy specimens taken from living patients and immediate postmortem samples which grew in about 80% of cases. Use of an appropriate medium for transport of specimens rather than sending them dry could improve success rates still further. The remaining skin samples were received from spontaneous abortions (often IUD) and stillbirths. For skin specimens from these sources, postmortem tissue maceration may be the most important factor. Selection of other fetal (for example, muscle) or extra-fetal specimens (for example, placental cord insertion site) instead of skin specimens should result in a dramatic improvement in overall success rates. This approach might be particularly valuable for stillbirths, where maceration has been associated with a higher rate of chromosome abnormality (10%) than unmacerated stillbirths (3.5%). 5 Culturing cord or cardiac blood samples may also provide a useful backup. If blood culture is successful then tissue culture need not be continued. The cytogenetic results from POC and placental biopsy specimens showed that maternal cell contamination was a serious problem irrespective of the tissue cultured. Identification and selection of fetal material for culture should always be attempted from POC to minimise this problem but in the majority of cases fetal tissue will not be available. Where a normal female chromosome complement is reported for such specimens, the need for a caveat on cytogenetic reports alerting the referring clinician to the possibility of a misleading result should be recognised. These results emphasise that for recurrent miscar-riages the most appropriate cytogenetic investigation is to analyse the chromosome complements of both parents from blood samples to exclude structural rearrangements. Studies on spontaneous abortions may still be justified following in vitro fertilisation assisted pregnancies" and those from parents with a known chromosome abnormality.
With an informed approach to sample selection and processing, the cytogenetic investigation of tissue biopsy specimens provides a valuable diagnostic service. This survey has highlighted areas where improvements can be made and provided evidence for a strategy for their achievement.
The ACC Solid Tissue Working Party Report7 made five recommendations for improving the quality of the service provided: * Laboratories should have a set of guidelines for the acceptance, transport and culture of specimens sent to the laboratory for dissemination to referring clinicians and other medical and nursing staff. 
